INTRODUCTION
============

Gastroesophageal reflux disease (GERD) is a chronic, progressive, and costly medical condition affecting a substantial proportion of the world population, predominantly the Western population. The first clinical description of GERD appeared in 1935 as a case report on severe peptic esophagitis \[[@b1-ce-2015-044]\]. GERD symptoms interrupt the activities of daily living and have been associated with significantly increased work absenteeism, reduced productivity at work \[[@b2-ce-2015-044]-[@b6-ce-2015-044]\], and increased healthcare resource utilization \[[@b6-ce-2015-044]\].

During the previous years, many medical and surgical treatment options have been devised; however, they all are expensive and pose significant adverse effects, which paved the way for the invention and advancement of effective endoscopic treatment options. Transoral incisionless fundoplication (TIF) is a unique form of natural orifice surgery, representing a next step in the field of minimally invasive surgery for the treatment of GERD.

TIF is an endoscopic luminal procedure that restores the antireflux competence of the gastroesophageal junction (GEJ), a critical step for effective long-term treatment of GERD. TIF is based on the principles of conventional antireflux surgery. It is done by using the EsophyX device (EndoGastric Solutions, Redmond, WA, USA), which is inserted transorally under endoscopic visual guidance to reconstruct the gastroesophageal valve (GEV) by wrapping the proximal part of the stomach (fundus) around the distal end of the esophagus, thus reestablishing the reflux barrier. The procedure involves placement of fasteners at four different positions to create a ≥270° valve that is 1 to 3 cm in length. Owing to this endoscopic incisionless approach, patients undergoing TIF experience less discomfort and faster recovery than those undergoing traditional antireflux surgery. Clinical studies have shown that TIF is an effective and safe treatment for mild to moderate GERD symptoms in carefully selected patients \[[@b7-ce-2015-044]\]. The major and minor adverse events experienced with TIF compares favorably with those reported for laparoscopic fundoplication \[[@b7-ce-2015-044]\]. TIF has helped patients in stopping acid-suppressive therapy, by maintaining or inducing the remission of GERD symptoms \[[@b8-ce-2015-044]\].

In this review article, we have summarized case series and reports describing the use of TIF for GERD patients. The indications, techniques, clinical response, endoscopic response, limitations, and complications reported are also discussed.

MATERIALS AND METHODS
=====================

An extensive English-language literature search was done by using PubMed, Medline, and Google to identify peer-reviewed original and review articles by using the key terms "endoscopic fundoplication" and "GERD." Only articles on human patients were selected. The references of pertinent studies were manually searched to identify additional relevant studies. The indication, procedural details, technical and clinical success rates, complications, and limitations were considered part of the inclusion criteria. The search yielded mostly retrospective and prospective studies with a modest sample size, including case reports, case series, and randomized controlled trials.

None of the authors have any conflicts of interest or financial relationship with the company that produces or distributes the device described in the review article.

RESULTS
=======

Ten original articles were considered appropriate for inclusion in this review. Among them, seven were prospective studies from the United States of America \[[@b8-ce-2015-044]-[@b10-ce-2015-044]\], Belgium \[[@b11-ce-2015-044]\], Netherlands \[[@b12-ce-2015-044],[@b13-ce-2015-044]\], and Italy \[[@b14-ce-2015-044]\]. Others included a retrospective study \[[@b15-ce-2015-044]\], a case report \[[@b16-ce-2015-044]\], and a prospective sham controlled trial \[[@b17-ce-2015-044]\] from the United States. All cases are summarized in [Table 1](#t1-ce-2015-044){ref-type="table"}.

Indications
-----------

Initially, TIF was approved by the Food and Drug Administration only for chronic GERD patients who are responsive to proton pump inhibitors (PPIs); however, over time, the inclusion criteria for TIF have expanded. Currently, the most common indication for TIF is either patients with refractory chronic GERD symptoms with only partial response to acid-suppressive medications \[[@b8-ce-2015-044]-[@b10-ce-2015-044],[@b12-ce-2015-044]-[@b15-ce-2015-044],[@b17-ce-2015-044]\], or those who do not want to continue lifelong medications despite being responsive to acid-suppressive medications \[[@b11-ce-2015-044],[@b13-ce-2015-044],[@b15-ce-2015-044]\]. Kumta et al. \[[@b16-ce-2015-044]\] described a unique case of TIF used for gastroesophageal reflux symptoms that developed after an endoscopic myotomy for underlying achalasia.

Exclusion criteria
------------------

The experience with TIF has grown in last few years but only to a specific segment of GERD patients. In nine of 10 studies included in our review, patients with a body mass index of \>35 kg/m^2^, hiatal hernia \>2 cm, grade D esophagitis according to the Los Angeles classification, esophageal motility disorder, and Barrett's esophagus were excluded from the study \[[@b8-ce-2015-044]-[@b15-ce-2015-044]\]. A history of failed antireflux surgery was also one of the exclusion criteria in a few studies \[[@b11-ce-2015-044]-[@b13-ce-2015-044]\].

Technique
---------

The EsophyX device has been designed by Endogastric Solutions for the treatment of GERD. The use of the EsophyX2 device with a flexible endoscope has been the method of choice for most physicians performing TIF.

The procedure is performed under general anesthesia and requires the assistance of two physicians (surgeons and/or gastroenterologists). The first physician controls the EsophyX device; thus, monitoring the appropriate application of fasteners to secure the newly created GEV, and the second physician ensures continuous direct visualization with the endoscope. The device creates a GEV by retracting full-thickness plications and through the tailored placement of multiple fasteners circumferentially around the GEJ \[[@b18-ce-2015-044]\].

There have been different versions of the TIF protocol with the major difference being in the degree of circumference of the reestablished valve, i.e., 220° in the 1.0 protocol versus 240° in the 2.0 protocol, and the location of the valve, i.e., at the level of the GEJ in the 1.0 protocol in contrast to the 2.0 protocol where the valve is created at a distance of 3 to 5 cm from the GEJ ([Fig. 1](#f1-ce-2015-044){ref-type="fig"}) \[[@b19-ce-2015-044]\]. Cadière et al. \[[@b11-ce-2015-044]\] described the use of the TIF 1.0 protocol in his study of 86 patients undergoing TIF with a mean wrap of 230° (160° to 300°), whereas the TIF 2.0 protocol was used in most of the other studies \[[@b8-ce-2015-044],[@b10-ce-2015-044],[@b13-ce-2015-044]-[@b15-ce-2015-044],[@b17-ce-2015-044]\] with a minimum reported wrap of 240° \[[@b10-ce-2015-044],[@b15-ce-2015-044]\] to as high as 300° \[[@b15-ce-2015-044]\]. In addition, the length of the reconstructed valve has been reported to vary from as low as 2 cm \[[@b10-ce-2015-044],[@b11-ce-2015-044],[@b15-ce-2015-044]\] to as high as 6 cm.11

Clinical response
-----------------

The authors have used a wide variety of objective scales to quantify the GERD symptoms before and after TIF, such as the GERD health-related quality of life (GERD-HRQL) \[[@b8-ce-2015-044],[@b10-ce-2015-044]-[@b15-ce-2015-044]\], GERD symptom score (GERSS) \[[@b10-ce-2015-044],[@b15-ce-2015-044]\], reflux symptom index (RSI) \[[@b8-ce-2015-044],[@b10-ce-2015-044],[@b15-ce-2015-044]\], reflux disease questionnaire (RDQ) \[[@b8-ce-2015-044],[@b17-ce-2015-044]\], and GERD quality of life (GERD-QUAL) \[[@b14-ce-2015-044]\]. Each of these scores, GERD-HRQL \[[@b20-ce-2015-044]\], GERSS \[[@b21-ce-2015-044]\], RSI \[[@b22-ce-2015-044]\], RDQ \[[@b23-ce-2015-044]\], and GERD-QUAL \[[@b24-ce-2015-044]\], have been validated for assessing the GERD symptom severity and the response to the treatment.

Trad et al. \[[@b8-ce-2015-044]\] described a significant decrease in the mean GERD-HRQL (26.25 to 5.41), mean RDQ (2.91 to 0.50), and mean RSI scores (22.0 to 4.79) after TIF at 12 months follow-up. The study also showed that the TIF group (mean GERD-HRQL \[26.25 to 5.23\], mean RDQ \[2.91 to 0.35\], and mean RSI scores \[22.0 to 4.64\]) showed better outcomes than the high-dose PPI group (mean GERD-HRQL \[26.43 to 18.86\], mean RDQ \[3.04 to 2.14\], and mean RSI scores \[22.62 to 19.62\]) at 6 months follow-up \[[@b8-ce-2015-044]\]. The high-dose PPI group showed further decreases in mean GERD-HRQL (18.86 to 10.05), mean RDQ (2.14 to 1.33), and mean RSI scores (19.62 to 8.76) at 6 months after TIF \[[@b8-ce-2015-044]\]. Toomey et al. \[[@b9-ce-2015-044]\] described the patient satisfaction scores (67%, 92%, and 86%) and the proportions of patients with a frequency of symptoms of \<1/month (83%, 92%, and 80%) at postintervention follow-up across three subgroups (TIF, Toupet fundoplication, and Nissen fundoplication). Wilson et al. \[[@b10-ce-2015-044]\] revealed a decrease in the median GERD-HRQL (24 to 2), median GERSS (26 to 4), and median RSI score (20 to 4) post-TIF at 12 months follow-up. Cadière et al. \[[@b11-ce-2015-044]\] showed a decrease in the median GERD-HRQL scores from 12 to 7 at 12 months post-TIF. Rinsma et al. \[[@b12-ce-2015-044]\] described a decrease in the mean GERD-HRQL score from 23.7 to 8.5 post-TIF in contrast to almost similar results in the mean GERD-HRQL scores (26.0 to 23.6) in the PPI study arm at 6 months follow-up. In another study, Rinsma et al. \[[@b13-ce-2015-044]\] showed a similar trend in the mean GERD-HRQL scores (27.5 to 13.2) post-TIF at 6 months follow-up. The study by Testoni et al. \[[@b14-ce-2015-044]\] did not show a significant difference in GERD-HRQL (from 20 to 17) and GERD-QUAL (84 to 80) post-TIF at 2 years follow-up. In another study by Trad et al. \[[@b15-ce-2015-044]\], the results showed a decreasing trend in median GERD-HRQL (26.0 to 4), median RDQ (24 to 3), and median RSI scores (17 to 4) post-TIF at 14 months follow-up. Hunter et al. \[[@b17-ce-2015-044]\], in a recent study, reported the elimination of troublesome regurgitation symptoms at 6 months follow-up in 54 of 81 patients (67%) who underwent TIF and placebo treatment, in contrast to 17 of 38 patients (45%) who underwent a sham procedure and PPI therapy. The trend in the median regurgitation RDQ score (3.5 to 0.5), median heartburn RDQ score (2.6 to 0.5), and composite median regurgitation and heartburn RDQ scores (3.1 to 0.6) among patients who underwent TIF and placebo medication was similar to that in patients who underwent a sham procedure and PPI treatment (median regurgitation RDQ score \[3.8 to 0.8\], median heartburn RDQ score \[3.0 to 0.8\], and composite median regurgitation and heartburn RDQ score \[3.3 to 0.9\]) at 6 months follow-up \[[@b17-ce-2015-044]\].

Overall, the results of the above studies seem to be reflective of the improvement in the quality of life of GERD patients after TIF.

Endoscopic response
-------------------

Trad et al. \[[@b8-ce-2015-044]\] described a significant decrease in the mean Demeester score (35.28 to 25.32) with normalization of esophageal pH in 45% (17 of 38) of patients, and healing of esophagitis in 100% of patients (19 of 19) post-TIF at 12 months follow-up. The study also showed that the TIF group (mean Demeester score \[35.28 to 23.64\] with normalization of esophageal pH in 54% of patients \[21 of 39\] and healed esophagitis in 90% of patients \[18 of 20\]) showed better outcomes than the high-dose PPI group (mean Demeester score \[35.79 to 19.29\] with normalization of esophageal pH in 52% of patients \[11 of 21\] and healed esophagitis in only 38% of patients \[5 of 13\]) at 6 months follow-up \[[@b8-ce-2015-044]\]. The high-dose PPI group showed further improvement in the proportion of patients with healed esophagitis (85%, 11 of 13) but a poor response reflected in the mean Demeester score (19.29 to 28.60) with normalization of esophageal pH in only 33% (7 of 21) of patients at 6 months after TIF \[[@b8-ce-2015-044]\]. Wilson et al. \[[@b10-ce-2015-044]\] reported normalization of esophageal acid exposure in 52% (14 of 27) of patients with healed esophagitis in 76% of patients post-TIF at 12 months follow-up. Cadière et al. \[[@b11-ce-2015-044]\] showed a decrease in the median Demeester score (34 to 28) post-TIF at 12 months follow-up. Rinsma et al. \[[@b12-ce-2015-044]\] described an improvement in distal baseline impedance (1,769 to 2,294 Ω) with a decrease in acid exposure time (9.7% to 6.9%) and mean acid reflux episodes (63.2 to 39.3) in the post-TIF group, which was comparable to those in the PPI group (improvement in distal baseline impedance \[1,088 to 2,470 Ω\]; decrease in acid exposure time \[12.4% to 5.9%\] and mean acid reflux episodes \[65.6 to 33.9\]) at 6 months follow-up. In another study, Rinsma et al. \[[@b13-ce-2015-044]\] showed an improvement in multiple endoscopically measured parameters, such as the mean GEJ distensibility (2.4 to 1.6 mm^2^/mm Hg), upright acid exposure time (11.7% to 6.6%), liquid reflux episodes (30.4% to 16.7%), and mean number of transient lower esophageal sphincter relaxation episodes (16.8 to 9.2) post-TIF at 6 months follow-up. Testoni et al. \[[@b14-ce-2015-044]\] also reported a mild improvement in Demeester score (22 to 19) with a decrease in the total number of reflux episodes (66 to 43) and an increase in lower esophageal sphincter pressure (8 to 12 mm Hg) post-TIF at 2 years follow-up. Trad et al. \[[@b15-ce-2015-044]\] reported only two patients at 14 months follow-up, with one showing normalization of esophageal pH and the other showing a decrease in Demeester score from 29 to 24.5. Hunter et al. \[[@b17-ce-2015-044]\] reported a statistically significant (*p*\<0.001) improvement in the Demeester score (33.6 to 23.9), percent time with pH \<4 (9.3% to 6.4%), and number of reflux episodes (135 to 94) in patients who underwent TIF and placebo treatment in contrast to those who underwent a sham procedure and PPI therapy (Demeester score \[30.9 to 32.7\], percent time with pH \<4 \[8.6% to 8.9%\], and number of reflux episodes \[125 to 122\]) at 6 months follow-up.

Overall, the results of the studies seem to be reflective of effective esophageal mucosal healing in most of the GERD patients after TIF, thus indirectly decreasing the risk of the complications of chronic GERD.

PPI requirement
---------------

The proportion of patients requiring PPIs to control their GERD symptoms is one of the indirect measures of efficacy of the underlying intervention for GERD.

Trad et al. \[[@b8-ce-2015-044]\] reported a significant decline in the proportion of daily PPI users (100% to 3%), with a concomitant increase in the proportion of occasional PPI users (0% to 15%) and those who do not use PPIs (0% to 82%) post-TIF at 12 months follow-up. The high-dose PPI group also showed a similar trend in the proportion of daily PPI users (100% to 10%) with a concomitant increase in the proportion of occasional PPI users (0% to 9%) and those who remain not using PPIs (0% to 71%) at 6 months after TIF \[[@b8-ce-2015-044]\]. Wilson et al. \[[@b10-ce-2015-044]\] reported a decline in the proportion of daily PPI users (92% to 23%) and occasional PPI users (8% to 3%) with concomitant increase in patients who remain not using PPIs (0% to 74%) after TIF at 12 months follow-up. Cadière et al. \[[@b11-ce-2015-044]\] also showed a decline in the proportion of daily PPI users (100% to 15%) with a concomitant increase in the proportion of occasional PPI users (0% to 16%) and those who remain not using PPIs (0% to 68%) after TIF at 12 months follow-up. Rinsma et al. \[[@b13-ce-2015-044]\] showed a similar trend, with 11 of 15 patients (73.3%) stopping their PPI use altogether and the remaining 4 of 15 users (26.7%) reporting daily use, but with 3 of the 4 daily users not able to decrease the daily dose of PPI, at 6 months after TIF. The study by Testoni et al. \[[@b14-ce-2015-044]\] was unique in comparison to the rest of the studies because of its long follow-up of 6 years. The results showed that after TIF, the proportion of daily PPI users decreased at 6 months (100% to 16.3%) and at 6 years (16.3% to 14.3%) follow-up. There was a concomitant increase in patients who were using half the PPI dose at 6 months (0% to 22.5%) and at 6 years (22.5% to 50.0%) follow-up \[[@b14-ce-2015-044]\]. In addition, the proportion of patients who have stopped PPI initially increased (0% to 61.2%) and then decreased (61.2% to 35.7%) at 6 years follow-up \[[@b14-ce-2015-044]\]. In another study, Trad et al. \[[@b15-ce-2015-044]\] reported a decreasing trend in the proportion of daily PPI users (89% to 18%) with a concomitant increase in the proportion of occasional PPI users (11% to 18%) and those who remain not using PPIs (0% to 64%) post-TIF at 14 months follow-up. Hunter et al. \[[@b17-ce-2015-044]\] reported that of 87 patients who underwent TIF with placebo treatment, 10 patients (11%) at 3 months follow-up and 24 patients (28%) at 18 months follow-up resumed PPI therapy because of the failure to resolve the GERD symptoms.

Overall, the results of the above studies are reflective of a significant decrease in the proportion of GERD patients requiring PPI after TIF, which indirectly has a major impact in decreasing the incidence of PPI-related complications among these patients.

Follow-up
---------

Most authors reported a follow-up period ranging from a minimum of 6 months \[[@b12-ce-2015-044],[@b13-ce-2015-044],[@b17-ce-2015-044]\] to a maximum of 6 years \[[@b14-ce-2015-044]\]. A total of 575 patients were studied in the 10 studies included in our review, among whom 22 patients were lost to follow-up. Despite a good follow-up, many patients with a successful control of symptoms after fundoplication might still be compliant to clinical questionnaire surveys on return visits but are nearly universally noncompliant to follow-up pH monitoring, thus leaving fewer patients for a comparison of the endoscopic outcomes.

TIF failure
-----------

Of the 575 total patients, 492 underwent TIF, 14 (2.84%) of whom required a repeat intervention. One patient underwent a repeat TIF procedure \[[@b10-ce-2015-044]\] and the other 13 required laparoscopic fundoplication \[[@b10-ce-2015-044],[@b11-ce-2015-044],[@b14-ce-2015-044],[@b15-ce-2015-044]\] Of these 13 cases, four were secondary to persistent GERD symptoms \[[@b14-ce-2015-044]\], two were secondary to esophageal perforation post-TIF \[[@b11-ce-2015-044]\], three were secondary to noncompliance to post-TIF dietary recommendations \[[@b10-ce-2015-044],[@b15-ce-2015-044]\], one was secondary to severe post-TIF vomiting \[[@b10-ce-2015-044]\], and the other three had unknown etiology \[[@b10-ce-2015-044],[@b11-ce-2015-044]\]. Hunter et al. \[[@b17-ce-2015-044]\] reported TIF failure in 10 of 87 (11%) patients at 3 months and 24 of 87 (28%) patients at 18 months follow-up, necessitating the resumption of PPI use; however, none of the patients underwent a repeat TIF or laparoscopic surgery. In the same study, Hunter et al. \[[@b17-ce-2015-044]\] reported that among the group who underwent sham surgery with placebo medication, 15 of 42 patients (35.7%) at 3 months and 30 of 42 patients (71.4%) at 18 months follow-up underwent TIF for persistent GERD symptoms.

Periprocedural complications (requiring extended hospital stay)
---------------------------------------------------------------

Of the 575 total patients, 492 underwent TIF, five (1.01%) of whom required an extended hospital stay secondary to the procedure-related complication. Of these five patients, two had esophageal perforation that required surgical treatment \[[@b11-ce-2015-044]\]; two had pneumothorax that was treated with transthoracic drainage \[[@b14-ce-2015-044]\]; and the other one had gastrointestinal bleeding that was treated with endoscopic clips, fibrin glue, and supportive blood transfusion \[[@b11-ce-2015-044]\].

Long-term procedure-related adverse effects (persistent/*de novo* \>1 month post-TIF)
-------------------------------------------------------------------------------------

Of the 575 total patients, 492 underwent TIF, of whom only eight (1.62%) were reported to have had symptoms that persisted beyond 1 month after TIF, or completely new symptoms that appeared 1 month after TIF that were attributed to the procedure. Three patients had worsening flatulence at 12 months follow-up \[[@b8-ce-2015-044],[@b10-ce-2015-044]\], two had *de novo* dysphagia at 12 months follow-up \[[@b10-ce-2015-044]\], one had *de novo* bloating at 12 months follow-up \[[@b10-ce-2015-044]\], one had persistent abdominal pain at 1 month follow-up \[[@b11-ce-2015-044]\], and the other one had persistent nausea at 1 month follow-up \[[@b11-ce-2015-044]\].

CONCLUSIONS
===========

TIF for chronic GERD can be a safe, minimally invasive, and equally efficacious alternative approach to surgery in selected patients who have refractory symptoms or are reluctant to take lifelong acid-suppressive medications or have contraindications to surgery. With the evolving technique and increasing experience, TIF seems to be a reasonable first-line approach for the management of a specific subgroup of patients with chronic GERD. The preliminary reports appear promising; however, larger multicentric prospective randomized sham-controlled trials with a longer follow-up and head-to-head comparison between PPI and other modalities for the treatment of GERD are needed in the future to ascertain its benefits before it can be adopted as a standard alternative therapy for patients with chronic GERD.
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![(A) Creation of esophagogastric fundoplication using the EsophyX device (EndoGastric Solutions). (B) Post procedure appearance-esophagogastric fundoplication proximal to the Z-line. Adapted from Bell et al. \[[@b19-ce-2015-044]\].](ce-2015-044f1){#f1-ce-2015-044}

###### 

Comparative Description of Different Studies Evaluating the Role of Transoral Incisionless Fundoplication

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study/country                                                                                   Type of study                                            Intervention                                    Indication                                                                                                                Exclusion criteria                                                                                                             Total subjects/subjects lost to follow-up   Instrument                                                                                                                  Technique/extent of wrap around the esophagus/length of reconstructed valve   Clinical response                                                   Endoscopic response                                                  PPI requirement                                                        Follow-up period   Peri-procedure complications (requiring extended hospital stay)                                      TIF failure requiring second endoscopic/surgical intervention                                                                                 Other complications (persistent \>1 mo, post TIF)   Miscellaneous facts
  ----------------------------------------------------------------------------------------------- -------------------------------------------------------- ----------------------------------------------- ------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------- ---------------------------------------------------------------------- ------------------ ---------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------- -----------------------------------------------------------------------------------
  Trad et al. (2014) \[[@b8-ce-2015-044]\] USA                                                    Prospective, randomized, multicenter, crossover study    TIF                                             1\. Daily regurgitation or atypical symptoms (Montreal criteria) on PPI\                                                  1\. BMI \>35\                                                                                                                  40/1                                        EsophyX-2 device via flexible endoscope                                                                                     TIF 2.0 protocol                                                              1\. Resolution of regurgitation and atypical symptoms\              1\. Healed esophagitis\                                              1\. Baseline\                                                          12 mo              None                                                                                                 None                                                                                                                                          Flatulence: 1/39                                    \-
                                                                                                                                                                                                           2. Abnormal 48 hr ambulatory pH test\                                                                                     2. Barrett's esophagus \>2 cm\                                                                                                                                                                                                                                                                                                                                                        1) 6 mo: 13/20 (65%)\                                               1) 6 mo: 18/20 (90%)\                                                1) Daily: 100%\                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                           3. H/O daily PPI use for at least 6 mo                                                                                    3. Hill grade valve III or IV\                                                                                                                                                                                                                                                                                                                                                        2) 12 mo: 30/39 (77%)\                                              2) 12 mo: 19/19 (100%)\                                              2) Occasional: 0%\                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                     4. Hiatal hernia \>2 cm in either dimension\                                                                                                                                                                                                                                                                                                                                         2. Mean GERDHRQL\                                                   2. Normalized esophageal pH\                                          3) None: 0%\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                     5. Los Angeles grade C or D classification                                                                                                                                                                                                                                                                                                                                            1) Baseline: 26.25\                                                 1) 6 mo: 21/39 (54%)\                                               2. 6 mo\                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 5.23\                                                      2) 12 mo: 17/38 (45%)\                                               1) Daily: 2%\                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 5.41\                                                    3. Mean Demeester score (48 hr pH study)\                             2) Occasionally: 8%\                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3. Mean RDQ\                                                         1) Baseline: 35.28\                                                  3) None: 90%\                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 2.91\                                                  2) 6 mo: 23.64\                                                     3. 12 mo\                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 0.35\                                                      3) 12 mo: 25.32                                                      1) Daily: 3%\                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 0.50\                                                                                                                          2) Occasionally: 15%\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          4. Mean RSI\                                                                                                                              3) None: 82%                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 22.00\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 4.64\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 4.79                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                           High dose PPI for first 6 mo, followed by TIF                                                                                                                                                                                                                                                            23/2                                        Maximal labelled dose of PPI, split into twice daily regimen for 6 mo followed by EsophyX-2 device via flexible endoscope   TIF 2.0 protocol                                                              1\. Resolution of regurgitation and atypical symptoms\              1\. Healed esophagitis\                                              1\. Baseline\                                                                             None                                                                                                 None                                                                                                                                          None                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) 6 mo: 1/21 (0.05%)\                                              1) 6 mo: 5/13 (38%)\                                                 1) Daily: 100%\                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 12 mo: 6/9 (67%)\                                                2) 12 mo: 11/13 (85%)\                                               2) Occasionally: 0%\                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2. Mean GERDHRQL\                                                   2. Normalized esophageal pH\                                          3) None: 0%\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 26.43\                                                 1) 6 mo: 11/21 (52%)\                                               2. 6 mo\                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 18.86\                                                     2) 12 mo: 7/21 (33%)\                                                1) Daily: 100%\                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 10.05\                                                   3. Mean Demeester score (48 hr pH study)\                             2) Occasionally: 0%\                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3. Mean RDQ\                                                         1) Baseline: 35.79\                                                  3) None: 0%\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 3.04\                                                  2) 6 mo: 19.29\                                                     3. 12 mo\                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 2.14\                                                      3) 12 mo: 28.60                                                      1) Daily: 10%\                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 1.33\                                                                                                                          2) Occasionally: 9%\                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          4. Mean RSI\                                                                                                                              3) None: 71%                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 22.62\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 19.62\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 8.76                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Toomey et al. (2014) \[[@b9-ce-2015-044]\] USA                                                  Case-control study with prospective follow-up            TIF                                             GERD refractory to or requiring open ended medical therapy                                                                1\. Hiatal hernia \>2 cm\                                                                                                      20                                          EsophyX-2 device via flexible endoscope                                                                                     DNA                                                                           1\. Patient satisfaction at follow-up: 67%\                         DNA                                                                  DNA                                                                    DNA                None                                                                                                 None                                                                                                                                          None                                                OT: 71 min HSL: 1 day
                                                                                                                                                                                                                                                                                                                                     2. Esophageal dysmotility                                                                                                                                                                                                                                                                                                                                                            2. Patients with symptom frequency (\<1/mo): 83%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

                                                                                                                                                           Toupet fundoplication                           GERD refractory to or requiring open ended medical therapy with abnormal esophageal motility                              1\. Failed surgical fundoplication in past                                                                                     20                                          DNA                                                                                                                         LESS                                                                          1\. Patient satisfaction at follow-up: 92%\                         DNA                                                                  DNA                                                                    DNA                DNA                                                                                                  NA                                                                                                                                            DNA                                                 OT: 85 min HSL: 1 day 10%: operation related complication (severity not reported)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2. Patients with symptom frequency (\<1/mo): 92%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

                                                                                                                                                           Nissen fundoplication                           GERD refractory to or requiring open ended medical therapy with normal esophageal motility                                1\. Failed surgical fundoplication in past\                                                                                    20                                          DNA                                                                                                                         LESS                                                                          1\. Patient satisfaction at follow-up: 86%\                         DNA                                                                  DNA                                                                    DNA                DNA                                                                                                  NA                                                                                                                                            DNA                                                 OT: 119 min HSL: 2 day 5%: procedure related complication (severity not reported)
                                                                                                                                                                                                                                                                                                                                     2. Esophageal dysmotility                                                                                                                                                                                                                                                                                                                                                            2. Patients with symptom frequency (\<1/mo): 80%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Wilson et al. (2014) \[[@b10-ce-2015-044]\] USA                                                 Prospective multicenter trial                            TIF                                             Chronic GERD (\>1 yr), daily PPI use \>6 mo, with unsatisfactory response                                                 1\. Hiatal hernia \>2 cm (axial), \>3 cm (transverse)\                                                                         100/4                                       EsophyX-2 device via flexible endoscope                                                                                     TIF 2.0 protocol 240--330 2--5 cm                                             1\. Median GERDHRQL\                                                1\. Esophagitis\                                                     1\. Baseline\                                                          12 mo              None                                                                                                 1\. 5/96: underwent LNF (1 had severe vomiting post procedure, 2 were non compliant with dietary instructions, other 2-unspecified reason)\   At 12 mo\                                           \-
                                                                                                                                                                                                                                                                                                                                     2. BMI \>35\                                                                                                                                                                                                                                                                                                                                                                          1) Baseline: 24\                                                    1) Healed (12 mo): 13/17 (76%)\                                      1) Daily: 92%\                                                                                                                                                                                2. 1/96: underwent repeat TIF                                                                                                                 1) *De novo* dysphagia: 2\                          
                                                                                                                                                                                                                                                                                                                                     3. Esophageal achalasia\                                                                                                                                                                                                                                                                                                                                                              2) 6 mo: 4\                                                         2) Improved (12 mo): 2/17 (12%)\                                     2) Occasionally: 8%\                                                                                                                                                                                                                                                                                                                        2) *De novo* bloating: 1\                           
                                                                                                                                                                                                                                                                                                                                     4. Barretts esophagus \>2 cm\                                                                                                                                                                                                                                                                                                                                                         3) 12 mo: 2\                                                       2. Esophageal acid exposure\                                          3) None: 0%\                                                                                                                                                                                                                                                                                                                                3) Worsening flatulence: 2                          
                                                                                                                                                                                                                                                                                                                                     5. Reflux esophagitisgrade D Los Angeles classification\                                                                                                                                                                                                                                                                                                                             2. Median GERSS\                                                     1) Normalization (12 mo): 14/27 (52%)                               2. 6 mo\                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                     6. Miscellaneous: gastroparesis, Zenker diverticulum, gastroparesis, scleroderma                                                                                                                                                                                                                                                                                                      1) Baseline: 26\                                                                                                                         1) Daily: 11%\                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 4\                                                                                                                              2) Occasionall: 9%\                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 4\                                                                                                                             3) None: 80%\                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3. Median RSI\                                                                                                                           3. 12 mo\                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 20\                                                                                                                         1) Daily: 23%\                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 6 mo: 5\                                                                                                                              2) Occasionally: 3%\                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 4                                                                                                                              3) None: 74%                                                                                                                                                                                                                                                                                                                                                                                    

  Cadière et al. (2008) \[[@b11-ce-2015-044]\]                                                    Prospective multicenter                                  TIF                                             18.80 yr, chronic GERD (\>6 mo) responsive to PPI therapy, with symptom recurrence on discontinuation of PPI for 14 day   1\. Irreducible hiatal hernia \>2 cm\                                                                                          86/7                                        EsophyX-2 device via flexible endoscope                                                                                     TIF 1.0 protocol 230 (160--300) 4 cm (2--6)                                   Median GERDHRQL\                                                    Median Demeester score\                                              1\. Baseline\                                                          12 mo              1\. Esophageal perforation 2/86: successfully repaired surgically\                                   3/86 LNF (2 were post perforation during TIF, and the third one-reason not specified)                                                         1\. Abdominal pain: 1/86\                           
                                                                                                                                                                                                                                                                                                                                     2. Previous failed anti-reflux surgery\                                                                                                                                                                                                                                                                                                                                              1) Baseline: 24\                                                    1) Baseline: 34\                                                      1) Daily: 100%\                                                                          2. Post TIF intraluminal bleedingtreated with endoscopic clips, fibrin glue, and blood transfusion                                                                                                                                                 2. Nausea: 1/86                                     
                                                                                                                                                                                                                                                                                                                                     3. BMI ≥35\                                                                                                                                                                                                                                                                                                                                                                          2) 6 mo: 5\                                                         2) 6 mo: 24\                                                          2) Occasional: 0%\                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                     4. Delayed gastric emptying\                                                                                                                                                                                                                                                                                                                                                         3) 12 mo: 7                                                         3) 12 mo: 28                                                          3) None: 0%\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                     5. Esophageal diseasemotility disorder, ulcer, biopsy proven Barretts, stricture\                                                                                                                                                                                                                                                                                                                                                                                                                                             2. 6 mo\                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                     6. Reflux esophagitisgrade D Los Angeles classification                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1) Daily: 14/86 (17%)\                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2) Occasionally: 14%\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    3) None: 69%\                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   3. 12 mo\                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1) Daily: 12/86 (15%)\                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2) Occasionally: 16%\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    3) None: 68%                                                                                                                                                                                                                                                                                                                                                                                    

  Rinsma et al. (2015) \[[@b12-ce-2015-044]\] Netherlands                                         Prospective, randomized, controlled, multicenter trial   Continuation of PPI therapy                     Chronic GERD (\>6 mo), partially responsive to acid suppressive medication                                                1\. Hiatal hernia \>2 cm\                                                                                                      15                                          NA                                                                                                                          NA                                                                            Mean GERD-HRQL\                                                     1\. Distal baseline impedance (Ω)\                                   NA                                                                     6 mo               NA                                                                                                   NA                                                                                                                                            NA                                                  \-
                                                                                                                                                                                                                                                                                                                                     2. Previous failed anti-reflux surgery\                                                                                                                                                                                                                                                                                                                                              1) Baseline: 26.0\                                                   1) Baseline: 1,088\                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                     3. BMI ≥35\                                                                                                                                                                                                                                                                                                                                                                          2) 6 mo: 23.6                                                        2) 6 mo: 2,470\                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                     4. Esophageal motility disorder on manometry\                                                                                                                                                                                                                                                                                                                                                                                                            2. Acid exposure time (%)\                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                     5. Barretts esophagus\                                                                                                                                                                                                                                                                                                                                                                                                                                    1) Baseline: 12.4\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                     6. Reflux esophagitisgrade D Los Angeles classification                                                                                                                                                                                                                                                                                                                                                                                                   2) 6 mo: 5.9\                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              3. Mean acid reflux episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1) Baseline: 65.6\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2) 6 mo: 33.9                                                                                                                                                                                                                                                                                                                                                                                                                                                         

                                                                                                                                                           TIF                                                                                                                                                                                                                                                                                                      32                                          EsophyX-2 device via flexible endoscope                                                                                     DNA                                                                           Mean GERD-HRQL\                                                     1\. Distal baseline impedance (Ω)\                                   DNA                                                                    6 mo               DNA                                                                                                  None                                                                                                                                          DNA                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1) Baseline: 23.7\                                                   1) Baseline: 1,769\                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2) 6 mo: 8.5                                                         2) 6 mo: 2,294\                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2. Acid exposure time (%)\                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1) Baseline: 9.7\                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               2) 6 mo: 6.9\                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              3. Mean acid reflux episodes\                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1) Baseline: 63.2\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               2) 6 mo: 39.3                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Rinsma et al. (2014) \[[@b13-ce-2015-044]\] Netherlands                                         Prospective single center study                          TIF                                             Chronic GERD (\>6 mo), on PPI therapy, dissatisfied or unwilling to continue lifelong PPI therapy                         1\. Hiatal hernia \>2 cm in length\                                                                                            15                                          EsophyX-TM device via flexible endoscope                                                                                    TIF 2.0 protocol                                                              Mean GERD-HRQL\                                                     1\. Mean EGJ distensibility (mm2/mm of Hg)\                          1\. Baseline\                                                          6 mo               DNA                                                                                                  None                                                                                                                                          DNA                                                 \-
                                                                                                                                                                                                                                                                                                                                     2. Previous failed anti-reflux surgery\                                                                                                                                                                                                                                                                                                                                              1) Baseline: 27.5\                                                   1) Baseline: 2.4\                                                    1) Daily: 100%\                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                     3. Esophageal stricture or ulcer\                                                                                                                                                                                                                                                                                                                                                    2) 6 mo: 13.2                                                        2) 6 mo: 1.6\                                                        2) None: 0%\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                     4. Esophageal motility disorder on manometry\                                                                                                                                                                                                                                                                                                                                                                                                            2. 24-hr ambulatory impedance pH (upright acid exposure time) (%)\   2. 6 mo\                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                     5. Barretts esophagus\                                                                                                                                                                                                                                                                                                                                                                                                                                    1) Baseline: 11.7\                                                   1) Daily (same dose): 1/15 (6.7%)\                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                     6. Reflux esophagitisgrade D Los Angeles classification\                                                                                                                                                                                                                                                                                                                                                                                                  2) 6 mo: 6.6\                                                        2) Daily (decreased dose): 3/15 (20%)\                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                     7. Current pregnancy\                                                                                                                                                                                                                                                                                                                                                                                                                                    3. 24-hr ambulatory impedance pH (liquid reflux episodes) (%)\        3) None: 11/15 (73.3%), but 1 used non PPI antisecretory medication                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                     8. Severe comorbidity-cardiopulmonary disorder, coagulation disorder, portal hypertension, immunosuppression, morbid obesity                                                                                                                                                                                                                                                                                                                              1) Baseline: 30.4\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               2) 6 mo: 16.7\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              4. Total no. of TLESR\                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1) Baseline: 16.8\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               2) 6 mo: 9.2                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Testoni et al. (2015) \[[@b14-ce-2015-044]\] Italy                                              Prospective single center study                          TIF                                             Symptomatic GERD, on PPI (standard dose twice a day) for a minimum of 3 mo                                                1\. Hiatal hernia \>3 cm\                                                                                                      50                                          EsophyX-TM device via flexible endoscope                                                                                    TIF 2.0 protocol                                                              1\. Mean GERDHRLQ\                                                  1\. pH metry, Johnson Demeester score\                               1\. 6 mo\                                                              6 yr               Pneumothorax: 2 subjectstreated successfully with immediate transthoracic drainage                   4/50 LNF at 12 mo secondary to persistent GERD symptoms                                                                                       DNA                                                 \-
                                                                                                                                                                                                                                                                                                                                     2. Previous esophageal, gastric or major abdominal surgery\                                                                                                                                                                                                                                                                                                                           1) Baseline (on PPI): 20\                                           1) Baseline: 22\                                                     1) Stopped PPI: 61.2%\                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                     3. Atypical GERD symptoms\                                                                                                                                                                                                                                                                                                                                                            2) Baseline (off PPI): 46\                                          2) 6 mo: 18\                                                         2) Halved PPI: 22.5%\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                     4. Biopsy prove Barretts esophagus\                                                                                                                                                                                                                                                                                                                                                   3) 12 mo: 16\                                                       3) 24 mo: 19\                                                        3) On PPI: 16.3%\                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                     5. Esophageal stricture\                                                                                                                                                                                                                                                                                                                                                              4) 24 mo: 17\                                                      2. Impedance, total refluxes (number)\                               2. 12 mo\                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                     6. Severe comorbidity-cardiopulmonary disease and collagen disease                                                                                                                                                                                                                                                                                                                   2. Mean GERDQUAL\                                                    1) Baseline: 66\                                                     1) Stopped PPI: 51.0%\                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline (on PPI): 84\                                           2) 6 mo: 38\                                                         2) Halved PPI: 28.6%\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) Baseline (off PPI): 114\                                         3) 24 mo: 43\                                                        3) On PPI: 20.4%\                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3) 12 mo: 71\                                                      3. LES pressure (mm Hg)\                                             3. 6 yr\                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           4) 24 mo: 80                                                        1) Baseline: 8\                                                      1) Stopped PPI: 35.7%\                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               2) 6 mo: 11\                                                         2) Halved PPI: 50.0%\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               3) 24 mo: 12                                                         3) On PPI: 14.3%                                                                                                                                                                                                                                                                                                                                                                                

  Trad et al. (2012) \[[@b15-ce-2015-044]\] USA                                                   Retrospective                                            TIF                                             1\. Persistent GERD and/LPR symptoms, not/partial controlled on antisecreatory medications\                               1\. Hiatal hernia, axial dimension \>2 cm                                                                                      34/6                                        EsophyX-2 device via flexible endoscope                                                                                     TIF 2.0 protocol 270 (240--300) 3 cm (2--4)                                   1\. Median GERDHRQL\                                                24-hr pH (only 2 subjects)\                                          1\. Baseline\                                                          14 mo              None                                                                                                 1/28 LNF (likely cause failure of dietary restriction post-TIF, causing disruption of reconstructed valve)                                    None                                                \-
                                                                                                                                                                                                           2. Either dissatisfied with current therapy or unwilling to continue taking medications indefinitely                                                                                                                                                                                                                                                                                                                                                                                                            1) Baseline: 26\                                                   1. First subject: Demeester score\                                    1) Daily: 25/28 (89%)\                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 14 mo: 4\                                                        1) Baseline: 29\                                                     2) Occasional: 3/28 (11%)\                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2. Median GRESS score\                                               2) Post-TIF at 14 mo: 24.5\                                          3) None: 0/28\                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 24\                                                   2. Second subject\                                                   2. 14 mo\                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 14 mo: 3\                                                        1) Baseline: abnormal pH\                                            1) Daily: 5/28 (18%)\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3. Median RSI\                                                       2) Post-TIF at 14 mo: normal pH                                      2) Occasionally: 5/28 (18%)\                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1) Baseline: 17\                                                                                                                         3) None: 18/28 (64%)                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2) 14 mo: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Kumta et al. (2015) \[[@b16-ce-2015-044]\] USA                                                  Case report                                              TIF                                             Subject with achalasia, who underwent peroral endoscopic myotomy and developed reflux symptoms refractory to PPI          None                                                                                                                           1                                           DNA                                                                                                                         270                                                                           DNA                                                                 DNA                                                                  DNA                                                                    DNA                DNA                                                                                                  DNA                                                                                                                                           DNA                                                 \-

  Hunter et al. (2015) \[[@b17-ce-2015-044]\] USA Prospective sham controlled mutlicenter study                                                            TIF f/b 6 mo of placebo treatmen                18.80 yr age group with chronic GERD (\>6 mo) symptoms and troublesome regurgitation despite daily PPI (40 mg) use        1\. Systemic disease: not well controlled\                                                                                     81/1                                        EsophyX-2 device via flexible endoscope                                                                                     TIF 2.0 protocol 270 (200--340) 3 cm (midportion); 1 cm (either corner)       1\. Elimination of troublesome regurgitation (6 mo): 54/81 (67%)\   1\. Total no. of reflux episodes\                                    By ITT analysis\                                                       6 mo               None                                                                                                 By ITT analysis\                                                                                                                              None                                                \-
                                                                                                                                                                                                                                                                                                                                     2. BMI \>35\                                                                                                                                                                                                                                                                                                                                                                         2. Median regurgitation RDQ score\                                  1) Baseline: 135\                                                    1) 3 mo: 10/87 (11%) resumed PPI\                                                                                                                                                              1. Treatment failure\                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                     3. Esophageal ulcer or stricture\                                                                                                                                                                                                                                                                                                                                                    1) Baseline (on PPI): 3.5 (3.4.3)\                                  2) 6 mo: 94\                                                         2) 18 mo: 24/87 (28%) resumed PPI                                                                                                                                                               1) 3 mo: 10/87 (11%), all resumed PPI, no other intervention done\                                                                                                                               
                                                                                                                                                                                                                                                                                                                                     4. Current pregnancy or plan of pregnancy in next 12 mo\                                                                                                                                                                                                                                                                                                                             2) 6 mo (on placebo): 0.5 (0.1.5)\                                  2. Percent time pH \<4\                                                                                                                                                                                                                                              2) 18 mo: 24/87 (28%), all resumed PPI, no other intervention done                                                                                                                               
                                                                                                                                                                                                                                                                                                                                     5. Hiatal hernia \>2 cm\                                                                                                                                                                                                                                                                                                                                                             3. Median Heartburn RDQ score\                                      1) Baseline: 9.3\                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                     6. Barrett's esophagus \>2 cm\                                                                                                                                                                                                                                                                                                                                                       1) Baseline (on PPI): 2.6 (1.5.3.8)\                                2) 6 mo: 6.4\                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                     7. Esophagitis: Grade C or D Los Angeles classification\                                                                                                                                                                                                                                                                                                                             2) 6 mo (on placebo): 0.5 (0.1.6)\                                  3. DeMeester Score\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                     8. Esophageal dysmotility\                                                                                                                                                                                                                                                                                                                                                           4. Composite median heartburn and regurgitation RDQ score\          1) Baseline: 33.6\                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                     9. Previous esophageal or gastric surgery\                                                                                                                                                                                                                                                                                                                                           1) Baseline (on PPI): 3.1 (2.4.3.8)\                                2) 6 mo: 23.9                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                     10. Peptic ulcer disease\                                                                                                                                                                                                                                                                                                                                                            2) 6 mo (on placebo): 0.6 (0.1.3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                     11. Gastric outlet obstruction or gastroparesis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                     12. Portal hypertension or coagulopathy\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                     13. Immunosuppression                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

                                                                                                                                                           Sham surgery f/b 6 mo of PPI therapy                                                                                                                                                                                                                                                                     38/1                                        EGD and 15 F maloney dilator                                                                                                30 min for EGD and 15 min for Maloney dilator                                 1\. Elimination of troublesome regurgitation (6 m): 17/38 (45%)\    1\. Total no. of reflux episodes\                                    DNA                                                                    6 mo               None                                                                                                 By ITT analysis\                                                                                                                              NA                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2. Median Regurgitation RDQ score\                                   1) Baseline: 125\                                                                                                                                                                                                                                                  1. Treatment failure\                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1) Baseline (on PPI): 3.8 (2.9.4.5)\                                 2) 6 mo: 122\                                                                                                                                                                                                                                                       1) 3 mo: 15/42 (35.7%), 12/15 underwent crossover to TIF\                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2) 6 mo (on PPI): 0.8 (0.2)\                                        2. Percent time pH \<4\                                                                                                                                                                                                                                              2) 18 mo: 30/42 (71.4%) underwent crossover to TIF                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          3. Median Heartburn RDQ score\                                       1) Baseline: 8.6\                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1) Baseline (on PPI): 3.0 (2.0.4.1)\                                 2) 6 mo: 8.9\                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2) 6 mo (on PPI): 0.8 (0.2)\                                        3. DeMeester score\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          4. Composite heartburn and regurgitation RDQ score\                  1) Baseline: 30.9\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1) Baseline (on PPI): 3.3 (2.5.4.0)\                                 2) 6 mo: 32.7                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2) 6 mo (on PPI): 0.9 (0.1.2.0)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PPI, proton pump inhibitor; TIF, transoral incisionless fundoplication; H/O, history of; BMI, body mass index; GERD-HRQL, gastroesophageal reflux disease-health-related quality of life; RDQ, reflux disease questionnaire; RSI, reflux symptom index; DNA, data not available; LESS, laparo-endoscopic single site; NA, not available; OT, operating time; HSL, hospital stay length; GERSS, GERD symptom score; LNF, laparoscopic Nissen fundoplication; EGJ, esophagogastric junction; TLESR, transient lower esophageal sphincter relaxation; LPR, laryngopharangeal reflux; f/b, followed by; ITT, intention-to-treat analysis.
